Suprasorb® A + Ag in the Treatment of Wounds at Risk of Infection and Infected Wounds

Inclusion Criteria: * Age ≥ 18 years * Patient is legally capable * Presence of a heavily exuding wound * Presence of one of the following wounds: * pressure ulcers * arterial ulcers * venous lower leg ulcers * diabetic ulcers OR * postoperative wound * skin graft and donor sites * Infected wound (TILI Score ≥ 5) or a wound with risk of infection (W.A.R. Score ≥ 3) * Wound area between 4 and 100 cm2 * It must be possible to display the entire wound area on one photo from a distance of 25-30 cm * Patient has signed a written Informed Consent Exclusion Criteria: * Treatment with Suprasorb® A + Ag Antimicrobial Calcium Algi-nate Wound Dressing and Rope or any silver containing dressing or topical drug during the last 3 weeks * Known sensitivity to Suprasorb® A + Ag Antimicrobial Calcium Alginate Wound Dressing and Rope or any of their components * Malignant wounds (tumor related wounds) * Critical limb ischemia * Infected wounds requiring systemic antibiotic therapy at baseline visit or infected wounds with surrounding skin requiring local an-tibiotics at baseline visit and/or during study conduct. * Severe sensitive neuropathy (9-10 points on the Neuropathie-Symptom-Score (Diagnose und Therapie der sensomotorischen diabetischen Neuropathien. Diabetes und Stoffwechsel, 11, Suppl.2 (2002)) * Planned amputation within the next 1 months * A planned surgical operation in the region of the study wound within the next 4 weeks following inclusion * Patient is not compli…